Back
Lexicon Pharmaceuticals Vs. Perspective Therapeutics Industry Stock Comparison
Sell
38
LXRX
Lexicon Pharmaceuticals
Last Price:
1.69
Seasonality Move:
7%
Sell
30
CATX
Perspective Therapeutics
Last Price:
13.38
Seasonality Move:
-6.23%
Sell
38
Lexicon Pharmaceuticals (LXRX)
is a Sell
Is Lexicon Pharmaceuticals a Buy, Sell or Hold?
- The current Lexicon Pharmaceuticals [LXRX] share price is $1.69. The Score for LXRX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- LXRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $13.35. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LXRX Stock Price Chart
What is Lexicon Pharmaceuticals's stock price today?
-
The Lexicon Pharmaceuticals share price today is $1.69
The current trend is relatively stagnant and LXRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $13.35
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight selling pressure.
LXRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 54.09 | Buy |
Chaikin Money Flow: | 1640628 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.58 - 1.68) | Buy |
Bollinger Bands (100): | (1.57 - 1.97) | Sell |
CATX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.34 | Sell |
Relative Strength Index (14 RSI): | 48.57 | Sell |
Chaikin Money Flow: | -57550 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.61 - 15.19) | Sell |
Bollinger Bands (100): | (11.44 - 14.98) | Buy |
LXRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.59 | Buy |
20-day SMA: | 1.63 | Buy |
50-day SMA: | 1.72 | Sell |
200-day SMA: | 1.88 | Sell |
8-day EMA: | 1.62 | Buy |
20-day EMA: | 1.63 | Buy |
50-day EMA: | 1.69 | Sell |
200-day EMA: | 1.81 | Sell |
CATX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.84 | Buy |
20-day SMA: | 13.59 | Sell |
50-day SMA: | 13.77 | Sell |
200-day SMA: | 11.83 | Buy |
8-day EMA: | 13.07 | Buy |
20-day EMA: | 13.39 | Sell |
50-day EMA: | 13.54 | Sell |
200-day EMA: | 11.64 | Buy |
Lexicon Pharmaceuticals Earnings Growth & LXRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.13 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.04 per share.
Lexicon Pharmaceuticals Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Perspective Therapeutics Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |